{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T18:05:53Z","timestamp":1759514753496},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,12,17]],"date-time":"2004-12-17T00:00:00Z","timestamp":1103241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,12,17]],"date-time":"2004-12-17T00:00:00Z","timestamp":1103241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2005,3,1]]},"DOI":"10.1038\/sj.cgt.7700774","type":"journal-article","created":{"date-parts":[[2004,12,17]],"date-time":"2004-12-17T10:21:56Z","timestamp":1103278916000},"page":"295-303","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus"],"prefix":"10.1038","volume":"12","author":[{"given":"Huijie","family":"Bian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Moormann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Schirrmacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,12,17]]},"reference":[{"key":"BF7700774_CR1","doi-asserted-by":"crossref","unstructured":"Schirrmacher V . Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved anti-tumor immune memory. Cancer Immunol Immunother. 2004 Oct 30.","DOI":"10.1007\/s00262-004-0602-0"},{"key":"BF7700774_CR2","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3748\/wjg.v9.i3.495","volume":"9","author":"W Liang","year":"2003","unstructured":"Liang W, Wang H, Sun TM, et al. Application of autologous tumor cell vaccine and NDV vaccine in treatment of tumors of digestive tract. World J Gastroenterol. 2003;9:495\u2013498.","journal-title":"World J Gastroenterol"},{"key":"BF7700774_CR3","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/BF03401771","volume":"4","author":"FM Batliwalla","year":"1998","unstructured":"Batliwalla FM, Bateman BA, Serrano D, et al. A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8T cell repertoire. Mol Med. 1998;4:783\u2013794.","journal-title":"Mol Med"},{"key":"BF7700774_CR4","first-page":"677","volume":"25","author":"V Schirrmacher","year":"1998","unstructured":"Schirrmacher V, Ahlert T, Probstle T, et al. Immunization with virus-modified tumor cells. Semin Oncol. 1998;25:677\u2013696.","journal-title":"Semin Oncol"},{"key":"BF7700774_CR5","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1200\/JCO.1997.15.4.1354","volume":"15","author":"T Ahlert","year":"1997","unstructured":"Ahlert T, Sauerbrei W, Bastert G, et al. Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer. J Clin Oncol. 1997;15:1354\u20131366.","journal-title":"J Clin Oncol"},{"key":"BF7700774_CR6","first-page":"21","volume":"2","author":"D Ockert","year":"1996","unstructured":"Ockert D, Schirrmacher V, Beck N, et al. Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma. Clin Cancer Res. 1996;2:21\u201328.","journal-title":"Clin Cancer Res"},{"key":"BF7700774_CR7","first-page":"618","volume":"5","author":"RM Lorence","year":"2003","unstructured":"Lorence RM, Pecora AL, Major PP, et al. Overview of phase I studies of intravenous administration of PV701, an oncolytic virus. Curr Opin Mol Ther. 2003;5:618\u2013624.","journal-title":"Curr Opin Mol Ther"},{"issue":"Part 4","key":"BF7700774_CR8","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1099\/vir.0.18884-0","volume":"84","author":"H Zhao","year":"2003","unstructured":"Zhao H, Peeters BP . Recombinant Newcastle disease virus as a viral vector: effect of genomic location of foreign gene on gene expression and virus replication. J Gen Virol. 2003;84(Part 4):781\u2013788.","journal-title":"J Gen Virol"},{"key":"BF7700774_CR9","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/03079450310001610695","volume":"32","author":"SO Al-Garib","year":"2003","unstructured":"Al-Garib SO, Gielkens AL, Gruys E, Peeters BP, Koch G . Tissue tropism in the chicken embryo of non-virulent and virulent Newcastle diseases strains that express green fluorescence protein. Avian Pathol. 2003;32:591\u2013596.","journal-title":"Avian Pathol"},{"key":"BF7700774_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0166-0934(02)00247-1","volume":"108","author":"I Engel-Herbert","year":"2003","unstructured":"Engel-Herbert I, Werner O, Teifke JP, Mebatsion T, Mettenleiter TC, Romer-Oberdorfer A . Characterization of a recombinant Newcastle disease virus expressing the green fluorescent protein. J Virol Methods. 2003;108:19\u201328.","journal-title":"J Virol Methods"},{"key":"BF7700774_CR11","first-page":"16","volume":"5","author":"Y Nagai","year":"1989","unstructured":"Nagai Y, Hamaguchi M, Toyoda T . Molecular biology of Newcastle disease virus. Prog Vet Microbio Immunol. 1989;5:16\u201364.","journal-title":"Prog Vet Microbio Immunol"},{"key":"BF7700774_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1386-6532(99)00072-4","volume":"16","author":"JG Sinkovics","year":"2000","unstructured":"Sinkovics JG, Horvath JC . Newcastle disease virus (NDV): brief history of its oncolytic strains. J Clin Virol. 2000;16:1\u201315.","journal-title":"J Clin Virol"},{"key":"BF7700774_CR13","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/ps\/82.6.899","volume":"82","author":"Z Huang","year":"2003","unstructured":"Huang Z, Elankumaran S, Panda A, Samal SK . Recombinant Newcastle disease virus as a vaccine vector. Poult Sci. 2003;82:899\u2013906.","journal-title":"Poult Sci"},{"key":"BF7700774_CR14","first-page":"85","volume":"21","author":"B Washburn","year":"2002","unstructured":"Washburn B, Schirrmacher V . Human tumor cell infection by Newcastle disease virus leads to upregulation of HLA and cell adhesion molecules and to induction of interferons, chemokines and finally apoptosis. Int J Oncol. 2002;21:85\u201393.","journal-title":"Int J Oncol"},{"key":"BF7700774_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1006\/viro.2002.1413","volume":"97","author":"J Zeng","year":"2002","unstructured":"Zeng J, Fournier P, Schirrmacher V . Induction of interferon-alpha and tumor necrosis factor-related apoptosis-inducing ligand in human blood mononuclear cells by hemagglutinin-neuraminidase but not F protein of Newcastle disease virus. Virology. 2002;97:19\u201330.","journal-title":"Virology"},{"key":"BF7700774_CR16","first-page":"945","volume":"18","author":"V Schirrmacher","year":"2001","unstructured":"Schirrmacher V, Griesbach A, Ahlert T . Antitumor effects of Newcastle disease virus in vivo: local versus systemic effects. Int J Oncol. 2001;18:945\u2013952.","journal-title":"Int J Oncol"},{"key":"BF7700774_CR17","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/sj.gt.3301974","volume":"10","author":"SD Barker","year":"2003","unstructured":"Barker SD, Dmitriev IP, Nettelbeck DM, et al. Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma. Gene Therapy. 2003;10:1198\u20131204.","journal-title":"Gene Therapy"},{"key":"BF7700774_CR18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0090-4295(03)00378-9","volume":"62","author":"W Jongmans","year":"2003","unstructured":"Jongmans W, van den Oudenalder K, Tiemessen DM, et al. Targeting of adenovirus to human renal cell carcinoma cells. Urology. 2003;62:559\u2013565.","journal-title":"Urology"},{"key":"BF7700774_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2174\/1566523023347797","volume":"2","author":"SA Nicklin","year":"2002","unstructured":"Nicklin SA, Baker AH . Tropism-modified adenoviral and adeno-associated viral vectors for gene therapy. Curr Gene Ther. 2002;2:273\u2013293.","journal-title":"Curr Gene Ther"},{"key":"BF7700774_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1046\/j.1365-2567.1997.00236.x","volume":"91","author":"S Horiuchi","year":"1997","unstructured":"Horiuchi S, Koyanagi Y, Tanaka Y, et al. Altered interleukin-2 receptor alpha-chain is expressed in human T-cell leukaemia virus type-I-infected T-cell lines and human peripheral blood mononuclear cells of adult T-cell leukaemia patients through an alternative splicing mechanism. Immunology. 1997;91:28\u201334.","journal-title":"Immunology"},{"key":"BF7700774_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1023\/A:1014416616687","volume":"22","author":"TA Waldmann","year":"2002","unstructured":"Waldmann TA . The IL-2\/IL-15 receptor systems: targets for immunotherapy. J Clin Immunol. 2002;22:51\u201356.","journal-title":"J Clin Immunol"},{"key":"BF7700774_CR22","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1073\/pnas.0437788100","volume":"100","author":"M Zhang","year":"2003","unstructured":"Zhang M, Zhang Z, Garmestani K, et al. Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia\/lymphoma xenografts. Proc Natl Acad Sci USA. 2003;100:1891\u20131895.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF7700774_CR23","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1128\/JVI.73.6.5001-5009.1999","volume":"73","author":"BP Peeters","year":"1999","unstructured":"Peeters BP, de Leeuw OS, Koch G, Gielkens AL . Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol. 1999;73:5001\u20135009.","journal-title":"J Virol"},{"key":"BF7700774_CR24","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/sj.cgt.7700535","volume":"9","author":"SJ Russell","year":"2002","unstructured":"Russell SJ . RNA viruses as virotherapy agents. Cancer Gene Ther. 2002;9:961\u2013966.","journal-title":"Cancer Gene Ther"},{"key":"BF7700774_CR25","doi-asserted-by":"publisher","first-page":"11354","DOI":"10.1073\/pnas.93.21.11354","volume":"93","author":"P Palese","year":"1996","unstructured":"Palese P, Zheng H, Engelhardt OG, Pleschka S, Garcia-Sastre A . Negative-strand RNA viruses: genetic engineering and applications. Proc Natl Acad Sci USA. 1996;93:11354\u201311358.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF7700774_CR26","first-page":"928","volume":"74","author":"U Schneider","year":"2000","unstructured":"Schneider U, Bullough F, Vongpunsawad S, Russell SJ, Cattaneo R . Recombinant measles viruses efficiently entering cells through targeted receptors. J Virol. 2000;74:928\u2013936.","journal-title":"J Virol"},{"key":"BF7700774_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S1525-0016(02)00033-3","volume":"7","author":"AD Bucheit","year":"2003","unstructured":"Bucheit AD, Kumar S, Grote DM, et al. An oncolytic measles virus engineered to enter cells through the CD20 antigen. Mol Ther. 2003;7:62\u201372.","journal-title":"Mol Ther"},{"key":"BF7700774_CR28","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1182\/blood-2002-07-2195","volume":"101","author":"KW Peng","year":"2003","unstructured":"Peng KW, Donovan KA, Schneider U, Cattaneo R, Lust JA, Russell SJ . Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker. Blood. 2003;101:2557\u20132562.","journal-title":"Blood"},{"key":"BF7700774_CR29","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1128\/JVI.75.5.2087-2096.2001","volume":"75","author":"AL Hammond","year":"2001","unstructured":"Hammond AL, Plemper RK, Zhang J, Schneider U, Russell SJ, Cattaneo R . Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen. J Virol. 2001;75:2087\u20132096.","journal-title":"J Virol"},{"key":"BF7700774_CR30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1006\/viro.2000.0618","volume":"278","author":"S Krishnamurthy","year":"2000","unstructured":"Krishnamurthy S, Huang Z, Samal SK . Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology. 2000;278:168\u2013182.","journal-title":"Virology"},{"issue":"Part 11","key":"BF7700774_CR31","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1099\/0022-1317-80-11-2987","volume":"80","author":"A Romer-Oberdorfer","year":"1999","unstructured":"Romer-Oberdorfer A, Mundt E, Mebatsion T, Buchholz UJ, Mettenleiter TC . Generation of recombinant lentogenic Newcastle disease virus from cDNA. J Gen Virol. 1999;80(Part 11):2987\u20132995.","journal-title":"J Gen Virol"},{"issue":"Part 7","key":"BF7700774_CR32","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1099\/0022-1317-82-7-1729","volume":"82","author":"Z Huang","year":"2001","unstructured":"Huang Z, Krishnamurthy S, Panda A, Samal SK . High-level expression of a foreign gene from the most 3\u2032-proximal locus of a recombinant Newcastle disease virus. J Gen Virol. 2001;82(Part 7):1729\u20131736.","journal-title":"J Gen Virol"},{"key":"BF7700774_CR33","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1006\/mthe.2001.0342","volume":"3","author":"DM Nettelbeck","year":"2001","unstructured":"Nettelbeck DM, Miller DW, Jerome V, et al. Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105). Mol Ther. 2001;3:882\u2013891.","journal-title":"Mol Ther"},{"key":"BF7700774_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/6185","volume":"17","author":"JS Bartlett","year":"1999","unstructured":"Bartlett JS, Kleinschmidt J, Boucher RC, Samulski RJ . Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab\u2032gamma)2 antibody. Nat Biotechnol. 1999;17:181\u2013186.","journal-title":"Nat Biotechnol"},{"key":"BF7700774_CR35","first-page":"5738","volume":"58","author":"CR Miller","year":"1998","unstructured":"Miller CR, Buchsbaum DJ, Reynolds PN, et al. Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Res. 1998;58:5738\u20135748.","journal-title":"Cancer Res"},{"key":"BF7700774_CR36","doi-asserted-by":"publisher","first-page":"9867","DOI":"10.1073\/pnas.96.17.9867","volume":"96","author":"AL Boerger","year":"1999","unstructured":"Boerger AL, Snitkovsky S, Young JA . Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types. Proc Natl Acad Sci USA. 1999;96:9867\u20139872.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF7700774_CR37","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1172\/JCI111992","volume":"76","author":"T Uchiyama","year":"1985","unstructured":"Uchiyama T, Hori T, Tsudo M, et al. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells. J Clin Invest. 1985;76:446\u2013453.","journal-title":"J Clin Invest"},{"key":"BF7700774_CR38","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.molmed.2003.10.001","volume":"9","author":"V Schirrmacher","year":"2003","unstructured":"Schirrmacher V, Feuerer M, Fournier P, Ahlert T, Umansky V, Beckhove P . T-cell priming in bone marrow: the potential for long-lasting protective anti-tumor immunity. Trends Mol Med. 2003;9:526\u2013534.","journal-title":"Trends Mol Med"},{"key":"BF7700774_CR39","first-page":"673","volume":"23","author":"P Fournier","year":"2003","unstructured":"Fournier P, Zeng J, Schirrmacher V . Two ways to induce innate immune responses in human PBMCs: paracrine stimulation of IFN-alpha responses by viral protein or dsRNA. Int J Oncol. 2003;23:673\u2013680.","journal-title":"Int J Oncol"},{"key":"BF7700774_CR40","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/35099560","volume":"413","author":"L Alexopoulou","year":"2001","unstructured":"Alexopoulou L, Holt AC, Medzhitov R, Flavell RA . Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 2001;413:732\u2013738.","journal-title":"Nature"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/7700774.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7700774","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7700774.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T13:49:34Z","timestamp":1647956974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/7700774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,17]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3,1]]}},"alternative-id":["BF7700774"],"URL":"https:\/\/doi.org\/10.1038\/sj.cgt.7700774","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,17]]},"assertion":[{"value":"20 May 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2004","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}